TRISENOX conc perf 12 mg/6ml 10 flac 6 ml
7680651780020
CH-65178
L01XX27
07.16.1.
Reimbursement limitations:
TRISENOX
Après confirmation préalable de prise en charge par l’assureur, après consultation du médecin-conseil.
Induction de …
1 / 2
google
Details
- Product number
- 6517802
- CPT
- -
- Packaging group
- 10
- Unit
- Durchstechflasche(n)
- Composition
- arsenii trioxidum 12 mg, natrii hydroxidum, natrii hydroxidi solutio 1 mol/L, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 6 ml corresp. natrium 4.14 mg.
Articles (1)
Trisenox 12 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
12.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
4.14 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 3450.75
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2020
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 65178
- Drug name
- Trisenox, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01XX27
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/12/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TRISENOX conc perf 12 mg/6ml 10 flac 6 ml
- Description (DE)
- TRISENOX Inf Konz 12 mg/6ml 10 Durchstf 6 ml
- Market launch
- 27/06/2019
- Narcotic (BTM)
- No